Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in the Treatment of Late-onset Sepsis in Preterm Neonates: a Multicentre, Randomised, Open-label, Non-inferiority Study.

NCT05981079 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT05981079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05981079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in the Treatment of Late-onset Sepsis in Preterm Neonates: a Multicentre, Randomised, Open-label, Non-inferiority Study.
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2023
Completion date
May 31, 2025
Enrollment
332 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

late-onset neonatal sepsis